SRZN - Surrozen, Inc./De

Insider Purchase by Kutzkey Tim (Dir, 10%)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Kutzkey Tim, serving as Dir, 10% owner at Surrozen, Inc./De (SRZN), purchased 32,507 shares at $19.74 per share, for a total transaction value of $641,597.00. Following this transaction, Kutzkey Tim now holds 2,261,777 shares of SRZN.

This purchase represents a 1.00% increase in Kutzkey Tim's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, January 15, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, January 20, 2026, 5 days after the trade was made.

Surrozen, Inc./De operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Kutzkey Tim

Kutzkey Tim

Dir, 10%

Tim Kutzkey, PhD is a Director and 10% Owner at Surrozen, Inc. (NASDAQ: SRZN), a clinical-stage biopharmaceutical company developing Wnt pathway-targeted therapies for tissue repair, regeneration, and oncology.[[1]](https://www.investing.com/news/insider-trading-news/surrozen-director-kutzkey-buys-srzn-stock-worth-641597-93CH-4456677)[[2]](https://www.marketbeat.com/instant-alerts/surrozen-nasdaqsrzn-director-tim-kutzkey-buys-2562-shares-of-stock-2026-01-20/)[[4]](https://surrozen.com/team/tim-kutzkey-phd/) He previously served on Surrozen's Board from April 2016 until June 2024 and as interim Chief Executive Officer from the company's inception to April 2018.[[4]](https://surrozen.com/team/tim-kutzkey-phd/) Kutzkey holds significant ownership, with recent Form 4 filings showing direct holdings of approximately 1,007,090 to 1,016,658 shares and indirect control through Column Group entities like The Column Group III, LP (900,292 shares) and The Column Group III-A, LP (1,016,658 shares).[[1]](https://www.investing.com/news/insider-trading-news/surrozen-director-kutzkey-buys-srzn-stock-worth-641597-93CH-4456677)[[2]](https://www.marketbeat.com/instant-alerts/surrozen-nasdaqsrzn-director-tim-kutzkey-buys-2562-shares-of-stock-2026-01-20/)[[3]](https://www.marketbeat.com/instant-alerts/surrozen-nasdaqsrzn-director-acquires-35381920-in-stock-2026-01-20/)[[5]](https://www.stocktitan.net/sec-filings/SRZN/form-4-surrozen-inc-de-insider-trading-activity-db9564078c54.html)[[6]](https://www.gurufocus.com/insider/125130/tim-kutzkey) As Managing Partner of The Column Group, LLC, a venture capital firm he joined in 2007, Kutzkey has extensive experience in biotech investments and leadership.[[4]](https://surrozen.com/team/tim-kutzkey-phd/)[[5]](https://www.stocktitan.net/sec-filings/SRZN/form-4-surrozen-inc-de-insider-trading-activity-db9564078c54.html)[[7]](https://investors.surrozen.com/static-files/ea12eef2-3894-495b-a0ba-f33af0033913)[[8]](https://nurabio.com/team/tim-kutzkey/) He is also a founding member and Chair of Nura Bio's board.[[8]](https://nurabio.com/team/tim-kutzkey/) Recently, between January 15-20, 2026, he purchased 32,907 SRZN shares worth $641,597 indirectly through Column Group funds, amid ongoing insider buying activity.[[1]](https://www.investing.com/news/insider-trading-news/surrozen-director-kutzkey-buys-srzn-stock-worth-641597-93CH-4456677)[[2]](https://www.marketbeat.com/instant-alerts/surrozen-nasdaqsrzn-director-tim-kutzkey-buys-2562-shares-of-stock-2026-01-20/)[[3]](https://www.marketbeat.com/instant-alerts/surrozen-nasdaqsrzn-director-acquires-35381920-in-stock-2026-01-20/)

View full insider profile →

Trade Price

$19.74

Quantity

32,507

Total Value

$641,597.00

Shares Owned

2,261,777

Trade Date

Thursday, January 15, 2026

38 days ago

SEC Filing Date

Tuesday, January 20, 2026

Filed 5 days after trade

HEALTHCAREBIOTECHNOLOGY

About Surrozen, Inc./De

Company Overview

No company information available
View news mentioning SRZN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3279200

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime